190 related articles for article (PubMed ID: 37176055)
1. Gene Expression Behavior of a Set of Genes in Platelet and Tissue Samples from Patients with Breast Cancer.
Burciaga-Hernandez LA; Cueto-Villalobos CF; Ortega-Piñon N; Gonzalez-Curiel IE; Godina-Gonzalez S; Mendez-Frausto G; Aguilar-Esquivel AP; Maldonado-Lagunas V; Guerrero-de la Torre LE; Melendez-Zajgla J; Sanchez-Garcia EK; Mitre-Aguilar IB; Mendoza-Almanza G
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176055
[TBL] [Abstract][Full Text] [Related]
2. Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis.
Yao B; Qu S; Hu R; Gao W; Jin S; Ju J; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2159-2169. PubMed ID: 31705785
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer.
Shibuya N; Kakeji Y; Shimono Y
Cancer Sci; 2020 Jun; 111(6):2093-2103. PubMed ID: 32307765
[TBL] [Abstract][Full Text] [Related]
7. Wasf3 Deficiency Reveals Involvement in Metastasis in a Mouse Model of Breast Cancer.
Qin H; Lu S; Thangaraju M; Cowell JK
Am J Pathol; 2019 Dec; 189(12):2450-2458. PubMed ID: 31542393
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer.
Anan K; Morisaki T; Katano M; Ikubo A; Kitsuki H; Uchiyama A; Kuroki S; Tanaka M; Torisu M
Surgery; 1996 Mar; 119(3):333-9. PubMed ID: 8619189
[TBL] [Abstract][Full Text] [Related]
9. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
10. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis.
Caine GJ; Lip GY; Blann AD
Ann Med; 2004; 36(4):273-7. PubMed ID: 15224653
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential tumor-educated platelets RNA biomarkers in non-small-cell lung cancer by integrated bioinformatical analysis.
Xue L; Xie L; Song X; Song X
J Clin Lab Anal; 2018 Sep; 32(7):e22450. PubMed ID: 29665143
[TBL] [Abstract][Full Text] [Related]
14. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
[TBL] [Abstract][Full Text] [Related]
16. Targeting WASF3 Signaling in Metastatic Cancer.
Loveless R; Teng Y
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467681
[TBL] [Abstract][Full Text] [Related]
17. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
Front Immunol; 2021; 12():807600. PubMed ID: 34987523
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma.
Zhu B; Gu S; Wu X; He W; Zhou H
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34806748
[TBL] [Abstract][Full Text] [Related]
19. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.
Cui YX; Bradbury R; Flamini V; Wu B; Jordan N; Jiang WG
Br J Cancer; 2017 Jun; 117(1):89-101. PubMed ID: 28571043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
